JP2015501820A5 - - Google Patents

Download PDF

Info

Publication number
JP2015501820A5
JP2015501820A5 JP2014546301A JP2014546301A JP2015501820A5 JP 2015501820 A5 JP2015501820 A5 JP 2015501820A5 JP 2014546301 A JP2014546301 A JP 2014546301A JP 2014546301 A JP2014546301 A JP 2014546301A JP 2015501820 A5 JP2015501820 A5 JP 2015501820A5
Authority
JP
Japan
Prior art keywords
compound
group
deuterated
hydrogen
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014546301A
Other languages
English (en)
Japanese (ja)
Other versions
JP5933746B2 (ja
JP2015501820A (ja
Filing date
Publication date
Priority claimed from CN2011104188590A external-priority patent/CN103159680A/zh
Application filed filed Critical
Publication of JP2015501820A publication Critical patent/JP2015501820A/ja
Publication of JP2015501820A5 publication Critical patent/JP2015501820A5/ja
Application granted granted Critical
Publication of JP5933746B2 publication Critical patent/JP5933746B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014546301A 2011-12-14 2012-12-13 イミダゾリジンジオン系化合物およびその用途 Active JP5933746B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201110418859.0 2011-12-14
CN2011104188590A CN103159680A (zh) 2011-12-14 2011-12-14 咪唑二酮类化合物及其用途
PCT/CN2012/086573 WO2013087004A1 (zh) 2011-12-14 2012-12-13 咪唑二酮类化合物及其用途

Publications (3)

Publication Number Publication Date
JP2015501820A JP2015501820A (ja) 2015-01-19
JP2015501820A5 true JP2015501820A5 (OSRAM) 2015-04-23
JP5933746B2 JP5933746B2 (ja) 2016-06-15

Family

ID=48583248

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014546301A Active JP5933746B2 (ja) 2011-12-14 2012-12-13 イミダゾリジンジオン系化合物およびその用途

Country Status (9)

Country Link
US (1) US9346764B2 (OSRAM)
EP (1) EP2792674B1 (OSRAM)
JP (1) JP5933746B2 (OSRAM)
CN (2) CN103159680A (OSRAM)
AU (1) AU2012350482B2 (OSRAM)
CA (1) CA2859224C (OSRAM)
ES (1) ES2587903T3 (OSRAM)
PL (1) PL2792674T3 (OSRAM)
WO (1) WO2013087004A1 (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014273618B2 (en) * 2013-05-29 2016-10-13 Hinova Pharmaceuticals Inc. Imidazole diketone compound and use thereof
RU2016110546A (ru) * 2013-09-19 2017-10-24 ГЛАКСОСМИТКЛАЙН ЭлЭлСи Комбинированная лекарственная терапия
CN106543085A (zh) * 2013-10-14 2017-03-29 杭州普晒医药科技有限公司 恩杂鲁胺的固态形式及其制备方法和用途
CN104803919A (zh) * 2014-01-26 2015-07-29 上海医药工业研究院 用于制备恩杂鲁胺中间体的方法
US10131636B2 (en) * 2014-10-01 2018-11-20 Laurus Labs Limited Process for the preparation of Enzalutamide
CN106432090B (zh) * 2015-10-30 2019-08-20 成都海创药业有限公司 一种氘代咪唑酮化合物的晶型及其制备方法和用途
CN107303278B (zh) * 2016-04-25 2020-11-13 成都海创药业有限公司 一种hc-1119固体分散体及其制备方法
CN107954936B (zh) * 2016-10-17 2021-03-19 海创药业股份有限公司 一种制备氘代咪唑二酮类化合物的方法
US20200000776A1 (en) 2017-02-13 2020-01-02 Kangpu Biopharmaceuticals, Ltd. Combination treating prostate cancer, pharmaceutical composition and treatment method
WO2019025250A1 (en) 2017-08-04 2019-02-07 Basf Se SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI
WO2019184952A1 (en) * 2018-03-29 2019-10-03 Hinova Pharmaceuticals Inc. Deuterated imidazolidinedione compounds and their uses
CN110372598A (zh) * 2018-04-13 2019-10-25 成都海创药业有限公司 一种合成氘代酰胺及氘代磺酰胺的新方法
CA3105389C (en) * 2018-05-14 2025-05-20 Hinova Pharmaceuticals Inc. HC-1119-BASED FORMULATION, PROCESS FOR PREPARATION AND USE OF THE LATTER
US20210386826A1 (en) 2018-11-05 2021-12-16 Pfizer Inc. Combination for Treating Cancer
CN112442009B (zh) * 2019-08-30 2023-10-03 润佳(苏州)医药科技有限公司 氘代化合物及其在治疗癌症方面的应用
US20230158152A1 (en) * 2020-03-17 2023-05-25 Medshine Discovery Inc. Proteolysis regulator and method for using same
CA3188821A1 (en) 2020-08-13 2022-02-17 Lars ANDERS Combination therapy
CN114181155A (zh) * 2021-12-21 2022-03-15 上海朝晖药业有限公司 碘-恩杂鲁胺及其制备方法及其应用
CN115181043B (zh) * 2022-07-27 2024-05-07 爱斯特(成都)生物制药股份有限公司 一种连续流制备4-异硫氰基-2-(三氟甲基)苯甲腈的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101782236B1 (ko) 2005-05-13 2017-09-26 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴히단토인 화합물
PT2368550E (pt) * 2006-03-27 2013-12-03 Univ California Modulador do receptor de androgénios para o tratamento de cancro da próstata e doenças associadas ao receptor de androgénios
CN101460467B (zh) * 2006-03-29 2012-09-19 加利福尼亚大学董事会 二芳基硫代乙内酰脲化合物
CN101817787B (zh) * 2009-02-26 2013-07-24 童友之 抗前列腺癌的雄性激素受体拮抗剂
CA2772579C (en) 2009-09-10 2015-12-08 Youzhi Tong Thioimidazolidinone androgen receptor antagonists and uses thereof
WO2013067151A1 (en) * 2011-11-02 2013-05-10 Medivation Prostate Therapeutics, Inc. Treatment methods using diarylthiohydantoin derivatives

Similar Documents

Publication Publication Date Title
JP2015501820A5 (OSRAM)
RU2488582C2 (ru) Бициклозамещенные азопроизводные пиразолона, способ их получения и фармацевтическое применение
JP2013543842A5 (OSRAM)
JP2013542261A5 (OSRAM)
JP2010500343A5 (OSRAM)
RU2015149767A (ru) Дейтерированные диаминопиримидиновые соединения и фармацевтические композиции, содержащие такие соединения
JP2015537020A5 (OSRAM)
JP2014511892A5 (OSRAM)
JP2014500861A5 (OSRAM)
JP2009263394A5 (OSRAM)
JP2010530897A5 (OSRAM)
JP2017524025A5 (OSRAM)
JP2011500758A5 (OSRAM)
RU2015108898A (ru) 3-ЦИКЛОГЕКСЕНИЛ И ЦИКЛОГЕКСИЛ ЗАМЕЩЕННЫЕ ИНДОЛЬНЫЕ И ИНДАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ RORгаммаТ И ИХ ПРИМЕНЕНИЯ
JP2015512943A5 (OSRAM)
JP2009542613A5 (OSRAM)
HRP20120202T1 (hr) AMIDOFENOKSIINDAZOLI, KORISNI KAO INHIBITORI c-MET
JP2014500870A5 (OSRAM)
JP2011518833A5 (OSRAM)
JP2007515465A5 (OSRAM)
JP2010529994A5 (OSRAM)
JP2016503414A5 (OSRAM)
JP2012512863A5 (OSRAM)
JP2011088926A5 (OSRAM)
JP2015500842A5 (OSRAM)